[CADL] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[CADL] Candel Therapeutics, Inc.
Announcement Date
11-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -173.74%
YoY- -208.52%
Quarter Report
CADL's Result
CADL's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 1,776 0 0 0 31 31 31 1375.20%
PBT -11,095 -8,435 -9,614 -8,795 -5,083 -8,688 -4,149 92.31%
Tax 386 -90 644 -940 -15,735 -193 -4,604 -
NP -11,095 -8,435 -9,614 -7,855 10,652 -8,495 455 -
Tax Rate - - - - - - - -
Total Cost 12,871 8,435 9,614 7,855 -10,621 8,526 -424 -
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -624.72 0.00 0.00 0.00 34,361.29 -27,403.23 1,467.74 -
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -0.38 -0.29 -0.33 -0.27 0.37 -0.29 0.02 -
EPS Diluted -0.38 -0.29 -0.33 -0.27 0.37 -0.29 0.02 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.